Table 1.

Demonstration of long-term responses after sipuleucel-T treatment in the STAMP study in subjects included in the current assessments^a

Subject	Antibody fold-change from week 0
	PSA		PAP
	Week 6	Week 26	Week 6	Week 26
Subject #1	2.40	2.98	4.87	4.40
Subject #2	5.52	4.91	7.86	7.65
Subject #3	2.94	3.58	6.96	6.81

^aResponses are described by prostate-specific antigen (PSA)- and prostatic acid phosphatase (PAP)-antibody fold-changes from week 0 to week 26. Methodology as described in Small et al. (8).